{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:18:48Z","timestamp":1790983128309,"version":"4.1.0"},"reference-count":17,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reports"],"abstract":"<jats:p>Background and Clinical Significance: The COVID-19 pandemic led to the rapid development of effective vaccination strategies. Although COVID-19 vaccines are generally safe, rare hematological adverse events have been reported, most prominently vaccine-induced immune thrombotic thrombocytopenia (VITT). Isolated cases of autoimmune cytopenias and bone marrow failure syndromes following COVID-19 vaccination have also been described. Case Presentation: We report the case of an 80-year-old male who developed subacute-onset severe normocytic anemia with reticulocytopenia and mild leukopenia following heterologous COVID-19 vaccination with ChAdOx1 nCoV-19 (AstraZeneca) and BNT162b2 (Pfizer\u2013BioNTech). Seven days after the second vaccination, mild anemia was detected, progressing over the following weeks to symptomatic anemia requiring hospitalization. Extensive diagnostic evaluation revealed no evidence of hemolysis, nutritional deficiency, autoimmune disease, or viral infection, including SARS-CoV-2 and Parvovirus B19. Bone marrow examination demonstrated an erythroid maturation arrest at the proerythroblast stage, resembling a pure red cell aplasia (PRCA)-like pattern. Cytogenetic and molecular analyses excluded myelodysplastic syndromes. Treatment with erythropoietin resulted in complete hematologic recovery. Conclusions: This case suggests that, in rare instances, COVID-19 vaccination may be temporally associated with transient suppression of erythropoiesis. Further studies are required to elucidate underlying mechanisms and to guide diagnosis and management.<\/jats:p>","DOI":"10.3390\/reports9030254","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:02:19Z","timestamp":1785830539000},"page":"254","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Subacute-Onset Anemia Following COVID-19 Vaccine Combination with ChAdOx (AstraZeneca) and BNT162b2 (BioNTech, Pfizer)\u2014A Case Report"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6141-339X","authenticated-orcid":false,"given":"Konstantina","family":"Salveridou","sequence":"first","affiliation":[{"name":"Department of Oncology, Hematology and Palliative Care, Marien Hospital, 40479 D\u00fcsseldorf, Germany"},{"name":"Department of Oncology, Hematology and Palliative Care, Rheinland Klinikum Neuss GmbH, 41464 Neuss, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Tzamalis","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hematology and Palliative Care, Marien Hospital, 40479 D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Haase","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hematology and Palliative Care, Marien Hospital, 40479 D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristoteles","family":"Giagounidis","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hematology and Palliative Care, Marien Hospital, 40479 D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/hematolrep14040050","article-title":"COVID-19 Adenoviral Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), COVID-19-Related Thrombosis, and the Thrombotic Thrombocytopenic Syndromes","volume":"14","author":"Allas","year":"2022","journal-title":"Hematol. Rep."},{"key":"ref_2","first-page":"297","article-title":"Aplastic Anemia Following COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series","volume":"18","year":"2024","journal-title":"Int. J. Hematol. Oncol. Stem Cell Res."},{"key":"ref_3","first-page":"1073258","article-title":"Autoimmune Hemolytic Anemia After mRNA COVID Vaccine","volume":"10","author":"Fatima","year":"2021","journal-title":"J. Blood Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3390\/hematolrep16040057","article-title":"Two Cases of Immune Thrombocytopenia (ITP) Related to Viral Vector Vaccination ChAdOx1-S (AstraZeneca) and a Good Response after Thrombopoietin Receptor Agonist (TPO-RA) Therapy","volume":"16","author":"Salveridou","year":"2024","journal-title":"Hematol. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1182\/blood-2016-05-717140","article-title":"Pure red cell aplasia","volume":"12","author":"Means","year":"2016","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2141.2008.07216.x","article-title":"Acquired pure red cell aplasia: Updated review of treatment","volume":"14","author":"Sawada","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101606","DOI":"10.1016\/j.tmaid.2020.101606","article-title":"Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis","volume":"36","author":"Huang","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.stemcr.2021.04.001","article-title":"Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2","volume":"16","author":"Shahbaz","year":"2021","journal-title":"Stem Cell Rep."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Choi, H.S., Kim, M.-H., Choi, M.G., Park, J.H., and Chun, E.M. (2023). Hematologic Abnormalities After COVID-19 Vaccination: A Large Korean Population-Based Cohort Study. medRxiv.","DOI":"10.1101\/2023.11.15.23298565"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1016\/j.vaccine.2023.04.066","article-title":"Hematologic Adverse Events Reported After COVID-19 Vaccination in the Philippines: A National Database Study","volume":"41","author":"Mesina","year":"2023","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jaip.2023.01.024","article-title":"Hypereosinophilia after Vaccination with the SARS-CoV-2 mRNA Vaccines","volume":"11","author":"Westreich","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1021\/acs.jproteome.0c00606","article-title":"Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients","volume":"19","author":"Thomas","year":"2020","journal-title":"J. Proteome Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Marchi, G., Bozzini, C., Bertolone, L., Dima, F., Busti, F., Castagna, A., Stranieri, C., Fratta Pasini, A.M., Friso, S., and Lippi, G. (2022). Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.932013"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e2022058","DOI":"10.1001\/jamanetworkopen.2020.22058","article-title":"Association of Red Blood Cell Distribution Width with Mortality Risk in Hospitalized Adults with SARS-CoV-2 Infection","volume":"3","author":"Foy","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1182\/asheducation.V2000.1.18.18","article-title":"New Insights into the Pathophysiology of Acquired Cytopenias","volume":"2000","author":"Young","year":"2000","journal-title":"Hematology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-016-1111-6","article-title":"Adjuvant Effects of a Sequence-Engineered mRNA Vaccine: Translational Profiling Demonstrates Similar Human and Murine Innate Response","volume":"15","author":"Edwards","year":"2017","journal-title":"J. Transl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"103479","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP Platform\u2019s Lipid Nanoparticle Component Used in Preclinical Vaccine Studies is Highly Inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"}],"container-title":["Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/3\/254\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:59:13Z","timestamp":1785833953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/3\/254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["reports9030254"],"URL":"https:\/\/doi.org\/10.3390\/reports9030254","relation":{},"ISSN":["2571-841X"],"issn-type":[{"value":"2571-841X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}